The Hague’s leading security hub welcomes UK cyber security firm CyNation

The UK Compliance & Information Security company CyNation has opened a new office in The Hague. CyNation helps organisations improve their information security and compliance posture by providing innovative, end-to-end cyber security and information compliance solutions. The company officially announced its arrival during the buzzing Cyber Security Week. CyNation’s Chairman, Steve Berry, was presented a welcome gift from InnovationQuarter’s Director of Foreign Investments Chris van Voorden during a kick-off ceremony at The Hague Security Delta.

Ambassadors and Trade Counsellors visit The Hague’s Cyber Security Week

On Tuesday 26 September a delegation of more than 70 Ambassadors and Trade Counsellors of many Embassies in The Hague honoured The Hague Security Delta with a visit during second edition of the Cyber Security Week.

CapitalFest presents 5 innovations that will change the world

The world is facing a number of major challenges, such as energy, climate, health and digital security. With enough capital, startups can solve many of these challenges. Therefore, on September 27, CapitalFest brings together hundreds of European startups with more than 100 billion private investment capital. In addition, CapitalFest presents 5 startup innovations that will change the world.

Cyber Security Week 2017 Starts

The top Dutch cyber specialists from government, businesses and knowledge institutions met this morning at The Hague Security Delta Campus for the official opening of the second edition of the Cyber Security Week. The message was loud and clear: with economic losses amounting to € 10 billion as a result of cybercrime in the past year, cyber security is one of the most urgent issues of today. Our digital resilience should be high on everyone’s agenda and this requires sufficient numbers of trained cyber security and IT-talent.

Groundbreaking Snake Venom Inspired Approach to Restore Blood Clotting in Patients Using Anticoagulants

VarmX, a Dutch, Leiden based biotech company focusing on the development of therapies in the field of hemostasis and thrombosis, today announced the publication in Nature Communications of a ground breaking LUMC study(1) on modified human factor X as a safe and effective reversal agent for prevention and treatment of bleeding in patients taking factor Xa oral anticoagulants. This new therapeutic factor X was inspired by a snake venom protein, and is the lead product in development of VarmX, a pharmaceutical LUMC spin off.

Ncardia Established Following Pluriomics Axiogenesis Merger

Ncardia has been established following the merger of Pluriomics and Axiogenesis. The privately held company with operations in Europe and the US, produces and commercializes high-quality, fully functional hiPSC derived cardiovascular and neuronal cell types and develops and realizes electrophysiology, biochemistry and contraction based assays for predictive safety pharmacology, toxicology testing and drug efficacy screenings.

Prince Constantijn van Oranje to continue his role as startup envoy of the Netherlands

The Minister of Economic Affairs, Henk Kamp, has invited Constantijn van Oranje to continue his mandate as StartupDelta’s special envoy for another year and a half.

National Geographic / This Tiny Country Feeds the World

The Netherlands has become an agricultural giant by showing what the future of farming could look like.

IBM reports record year for inward investment in the Netherlands

The Global Location Trends 2017 Annual Report, released annually by IBM, reports a record year of inward investments for the Netherlands. Holland also ranks highly for average job value of investment projects.

Hercules Pharmaceuticals receives investment from UNIIQ for the development of cancer immunotherapy

Hercules Pharmaceuticals, a Boston University spin-off company, currently located at the Leiden Bioscience Park, will receive a € 300,000 investment from the UNIIQ investment fund for the further development of its lead compound, an immunotherapeutic for different forms of cancer. The investment was announced at the UNIIQ Live event by Ivo de Nooijer, director of LURIS, the Technology Transfer Office of Leiden University.

Human Metabolome Technologies chose Leiden for its European office

Japanese firm Human Metabolome Technologies (HMT) has chosen Leiden for its European office and started operations July 1st 2017 at the Leiden Bio Science Park. This biotechnology company develops capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technologies and solutions to drive drug discovery, diagnosis, and food production. At the opening ceremony HMT’s CEO Mr. Ryuji Kanno and Managing Director Mr. Tsutomu Hoshiba were presented a special plaque from Mayor Henri Lenferink to mark the occasion. The Ambassador of Japan, Mr. Hiroshi Inomata also gave a brief speech during the official opening ceremony.

Australian space startup Fleet expands into Europe with Dutch office opening

Australian space startup, Fleet, is expanding it's operations to Europe by establishing an office in Dutch space hub, Delft. The move comes as Fleet readies to launch the first of its 100 strong nanosatellite constellation in early 2018. Fleet is building a nanosatellite network to deliver connectivity for the internet of things for free.